US20080125862A1 - Two part "L" -shaped Phakic IOL - Google Patents
Two part "L" -shaped Phakic IOL Download PDFInfo
- Publication number
- US20080125862A1 US20080125862A1 US11/980,387 US98038707A US2008125862A1 US 20080125862 A1 US20080125862 A1 US 20080125862A1 US 98038707 A US98038707 A US 98038707A US 2008125862 A1 US2008125862 A1 US 2008125862A1
- Authority
- US
- United States
- Prior art keywords
- lens
- haptic
- optic
- eye
- eyelet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000463 material Substances 0.000 claims description 46
- 239000002033 PVDF binder Substances 0.000 claims description 3
- 239000004642 Polyimide Substances 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 3
- 229920002492 poly(sulfone) Polymers 0.000 claims description 3
- 239000004417 polycarbonate Substances 0.000 claims description 3
- 229920000515 polycarbonate Polymers 0.000 claims description 3
- 229920006393 polyether sulfone Polymers 0.000 claims description 3
- 229920001721 polyimide Polymers 0.000 claims description 3
- 239000011116 polymethylpentene Substances 0.000 claims description 3
- 229920000306 polymethylpentene Polymers 0.000 claims description 3
- -1 polypropylene Polymers 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 3
- 239000004696 Poly ether ether ketone Substances 0.000 claims description 2
- 239000004695 Polyether sulfone Substances 0.000 claims description 2
- 229920002530 polyetherether ketone Polymers 0.000 claims description 2
- 238000004873 anchoring Methods 0.000 claims 1
- 210000000695 crystalline len Anatomy 0.000 description 107
- 210000001508 eye Anatomy 0.000 description 53
- 210000002683 foot Anatomy 0.000 description 24
- 239000010408 film Substances 0.000 description 19
- 210000002159 anterior chamber Anatomy 0.000 description 16
- 238000000034 method Methods 0.000 description 16
- 210000003371 toe Anatomy 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 10
- 238000003780 insertion Methods 0.000 description 9
- 230000037431 insertion Effects 0.000 description 9
- 239000000835 fiber Substances 0.000 description 8
- 230000008901 benefit Effects 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 238000000465 moulding Methods 0.000 description 6
- 229920000491 Polyphenylsulfone Polymers 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 229920001971 elastomer Polymers 0.000 description 5
- 239000000806 elastomer Substances 0.000 description 5
- 239000007943 implant Substances 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 4
- 238000002513 implantation Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 210000004087 cornea Anatomy 0.000 description 3
- 239000013536 elastomeric material Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000003754 machining Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 206010002945 Aphakia Diseases 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000003851 corona treatment Methods 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000007779 soft material Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 201000009310 astigmatism Diseases 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005422 blasting Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 238000007524 flame polishing Methods 0.000 description 1
- 230000004313 glare Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000004297 night vision Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 238000007517 polishing process Methods 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 210000001745 uvea Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/16—Intraocular lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/1681—Intraocular lenses having supporting structure for lens, e.g. haptics
- A61F2002/16902—Separable from intraocular lens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0033—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementary-shaped recess, e.g. held by friction fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0043—L-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0018—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
Definitions
- the present invention generally relates to a two part “L”-shaped IOL. More specifically, the present invention relates to an IOL film frame which is insertable through an opening as small as 1.0 mm without deforming the frame and a lens which can then be attached within the eye.
- Intraocular lenses can be used to treat a wide diversity of eye conditions ranging from cataracts to any type of eyesight correction.
- IOLs can be used to replace an irreversibly damaged lens in the eye—aphakic eyes.
- the lenses can be used in addition to the natural lens to correct the vision—phakic eyes. These lenses can be placed in the anterior or posterior chambers of the eye.
- the second location is the angle between the cornea and the iris.
- Angle supported anterior chamber IOLs took advantage of the anterior chamber angle to support and fix the IOL in place. By angling the IOL into opposite sides of the anterior chamber, the natural angle was used to keep the IOL from moving.
- early lenses experienced marked problems with endothelial loss due to chafing against the early thick lenses. Later lenses were able to reduce the significance of this problem, but still retained problems associated with placement of the IOL in the chamber angle.
- the biological properties of that angle make it a very sensitive area.
- the structures associated with equalizing the internal pressure of the eye are located in that area. Additionally, the tissue in the area is easily irritated and irritation initiates a growth of fibrous tissue, called synechiae.
- the IOL fixation must be gentle in order to reduce irritation, but stable enough that it will not be easily moveable. This compromise is difficult to obtain.
- results were excellent in the short-term, there was a significant problem in the long term with altered night vision, loss of endothelial cell populations and alteration of the anterior uvea.
- ICL's implantable contact lenses.
- the ICL's are suspected of initiating cataracts and glaucoma.
- a typical IOL is composed of an optic, the ‘lens’ part of the structure, and a mounting mechanism called a haptic.
- the haptics are the part of the IOL that comes in contact with the eye tissue to hold the lens optic in place.
- Fiber haptics are slender strands of resilient material which are attached at one end to the optic, and which rest, at their other end, against the eye. Fiber haptics have the advantage of being very light and slender. This would seem to make them ideal by causing less damage to the tissue and additionally being aesthetically pleasing because they are very narrow.
- Plate haptics are machined or molded from stock materials and have a central optic and an outer perimeter which rests against the eye. Because of their size, plate haptics tend to be more easily seen from outside in the patient's eye and the addition of extra material weight to the IOL and reduced flexibility as compared to fiber haptics leads to poor fixation and consequent migration or dislocation of the IOL. While, fiber haptics have the disadvantage of initiating a process in which the body builds fibrous tissue or synechiae around the fiber haptic which immobilizes the iris, the larger plate haptic very rarely, if ever, causes such a reaction.
- the surgical process may or may not include removal of the diseased natural lens using a process called phakoemulsification.
- phakoemulsification The more standardized procedure for lens implantation involves removal of a diseased natural lens followed by implantation of an artificial lens. Phakoemulsification of the diseased lens is accomplished through about a 2 to 4 mm (small) incision in the eye and through a capsulorhexis incision in the capsule that encloses the lens in the posterior chamber, then an artificial intraocular lens implant is implanted back through the capsulorhexus into the capsular bag.
- the natural lens may not require removal at all.
- an intraocular lens has been developed.
- the intraocular lens features an optic and a haptic.
- the haptic is “V”-shaped and features relatively more rigid elements formed of relatively higher modulus (harder) materials which are flexibly springy when thin.
- the haptics may also comprise less rigid elements formed of relatively lower modulus (softer) materials bridging a discontinuity separating the haptics.
- the “V”-shaped haptic allows for insertion of the haptic through an opening in the eye as small as about 1 mm without deforming the frame.
- the haptic also features a fastening structure for the separate optic, preferably a cleat. The foldable optic is then inserted into the eye through the same ultra small incision and attached to the haptic, preferably the haptic cleat, by way of a formed aperture or eyelet in the optic.
- the higher modulus springy polymeric material may be selected from polyimide, polyetheretherketone, polycarbonate, polymethylpentene, polymethylmethyl methacrylate, polypropylene, polyvinylidene fluoride, polysulfone, and polyether sulfone.
- the higher modulus material is polyphenylsulfone (PPSU).
- PPSU polyphenylsulfone
- the higher modulus material has a modulus of elasticity of about 100,000 to about 500,000 psi, even more preferably about 340,000 psi and has a hardness of about 60 to 95 on the shore D scale, but more specifically a Rockwell R hardness of 120 to 130.
- the lower modulus rubbery material may be an elastomer selected from silicones, urethane, or hydrophilic acrylics.
- the lower modulus elastomeric material has a modulus of about 100 to about 1000 psi (unit load at 300% elongation).
- lower modulus material has a hardness of about 15 to 70 on the shore A scale of hardness.
- the lower modulus material is a dispersion such as NUSIL MED 6605, 6400, 6820, 6604, and 6607, or the like.
- the relatively more rigid elements comprises a “V”-shaped frame.
- the frame forms three haptics which may be formed from a single uniform piece of material.
- the haptic may contain a cleat for attachment of the lens.
- the haptic may additionally contain a slot open on one side to form a hinge which is bendable at the slot.
- the haptic may alternatively contain a groove to form a hinge which is bendable at the groove.
- the lower modulus material may partially or completely cover the haptics. In one embodiment, the lower modulus material is extended beyond the tip of the haptic to produce a softer contact point for the eye tissue.
- the lower modulus material may be applied by first surface treating the higher modulus material and then molding the lower modulus material onto the treated surface.
- the surface treatment is a corona or plasma treatment and additionally a primer.
- the molding is dip molding, cast molding, or injection molding. Primers such as Nusil Med may also be used singly or in combination.
- the invention is a “V”-shaped intraocular lens frame, having multiple plate haptic elements preferably formed of relatively higher modulus harder material and containing an attachment for a separate optic.
- the invention may optionally have a hinge connecting the toe region to the foot region, the hinge being formed of relatively lower modulus material. This can be referred to as a “duplex” material.
- the optic may be any type of lens.
- the optic is a refractive lens, or an interference lens, producing a thin optic.
- the optic could be toric, aspheric, multi-element, positive or negative.
- the invention is an intraocular lens having an optic; and a haptic including stiffer elements joined by flexible elements of different materials.
- the invention is a method for making an intraocular lens haptic, having the steps of forming a frame, coating a location of the frame, and breaking the frame at the location.
- the invention is a method of mounting a lens in the anterior chamber of an eye, having the steps of supporting a lens on a plate haptic at the angle of the anterior chamber; and bending the haptic at a preferential hinge line to reduce pressure against the angle.
- FIG. 1 is a simplified representation of the cross-sectional physiology of the eye with an anterior IOL in accordance with the preferred embodiment implanted.
- FIG. 2A is a plan view of the multi-part IOL in accordance with the preferred embodiment within the eye.
- FIG. 2B is a plan view of an alternate embodiment of the positioning of the cleat in accordance with the preferred embodiment.
- FIG. 2C is a side view of the multi-part IOL in accordance with the preferred embodiment.
- FIG. 3 is a plan view of the haptic in accordance with the preferred embodiment.
- FIGS. 4A-C are plan and side views of the cleat and eyelet used to attach the ocular onto the haptic.
- FIG. 5A-H is a plan view of the haptic and lens being inserted into an eye through an ultra-small incision.
- the arrows indicate which way the haptic is moved to allow insertion without deformation.
- FIGS. 6A-C are plan views of alternative “L”shapes for the haptic of the invention.
- FIG. 7 is a plan view of a preferred embodiment of the haptic containing hinged feet.
- FIG. 8A-H are plan views of alternative embodiments of the invention.
- a haptic in the form of a “V”-shape has been developed for a two part IOL.
- This thin film frame haptic is insertable through an opening in the eye as small as about 1 mm without deformation of the haptic.
- This film frame haptic is also lightweight, springy and non-irritating, low cost, surgically implantable with a minimum of trauma to the eye, aesthetically pleasing, and does not support fibrous tissue growth.
- This IOL works in the anterior or posterior chamber of the eye for phakic or aphakic lenses.
- This haptic additionally comprises a fastener for a separate optic.
- This “V”-shaped IOL film frame is a haptic system based on a high modulus, shaped skeletal frame or plate haptic.
- the haptic system may optionally be assembled with low modulus, soft, elastomeric hinged zones.
- the more rigid frame or haptic in combination with the soft hinges ensures that the lens and haptic assembly will maintain its shape and stay ideally situated in the anterior chamber angle of the eye or in the posterior chamber.
- a haptic of a single soft material will not maintain a desirable shape and will be more noodle-like in its spirit, the compliant hinge can automatically adjust to the normal movements of an eye.
- the cornea 12 serves as a refracting medium in addition to its function as the anterior wall of the eye 1 .
- the pupil 14 and the iris 15 of variable aperture are located behind the cornea 12 and divide the eye 1 into an anterior chamber 16 and a posterior chamber 18 .
- the natural crystalline lens 30 is connected by zonular fibers to a peripheral muscle about the lens 30 known as the ciliary muscle 20 .
- the more standardized procedure for the removal of a diseased natural lens 30 followed by implantation of an artificial lens involves the phakoemulsification of the diseased lens through a small incision in the eye and through a capsulorllexis incision in the capsule that encloses the lens in the posterior chamber 18 , then an artificial intraocular lens implant is implanted back through the capsulorhexus into the capsular bag.
- the natural lens 30 may not require removal at all.
- the optic 200 of the IOL 10 used in these procedures includes a separate centrally located optical zone and may be configured for implantation into either the anterior 16 or posterior chamber 18 and may be used for either procedure set out above.
- the haptic 110 of the IOL 10 extends radially outwardly in the general plane of the optic 200 .
- FIGS. 2 and 3 are plan views of the film frame haptic of a plural part IOL 10 in accordance with the preferred embodiment.
- the intraocular lens 10 is generally comprised of a lens optic 200 and a lens frame haptic 110 .
- the film frame haptic 110 includes three feet 121 and two cross bars 190 .
- the three feet 121 and two cross bars 121 are arranged in an approximately “L”-shape.
- L By “L” shape, it is envisioned that there is at least one “corner” or “angle” 122 which is as great as 135° or more, but preferably at about a 90° angle or less, preferably between 35 and 60° (angular degrees) and more preferably about 45°.
- This arrangement allows the haptic to be inserted into a very small incision without deformation of the haptic.
- the very small incision is preferably less than 3 mm, more preferably less than 2 mm, and even more preferably less than 1.5 nm and most preferably less than about 1.0 mm.
- the maximum dimension across the width of the haptic 110 is less than the incision.
- the incision in the eye can be stretched without damage to the tissue. For example, it has been observed that a 2.5 mm incision can be stretched to as much as 3 mm, to allow passage of a 3 mm wide haptic arm.
- each foot 121 may have a hinge region 120 which can be configured in a number of ways, but has the property of being more elastic than the main body of the foot 121 .
- This hinge region 120 is formed of a material which is more elastic than the remainder of the lens frame haptic 110 .
- the hinge region 120 is covered in an elastomeric material 127 which extends between the foot 121 and toe 150 .
- the hinge zone 120 can be a thinner section in the frame, or a discontinuous opening in the frame where the elastomer 127 extends between the foot zone 121 and the toe portion 150 .
- the hinge 120 and toe 150 can be produced in a variety of ways which are described in detail in application Ser. No. 09/_______, filed May 12, 2000.
- the separate lens optic 200 can be any type of lens, elastomeric or polymeric optical material.
- the optic 200 can be a simple refractive lens, a monofocal, toric or aspheric, a bifocal, an interference lens, a positive lens or a negative lens.
- the lens can be made thinner by using the polychromatic diffractive lens disclosed in U.S. Pat. No. 5,589,982 which is hereby incorporated herein by reference.
- a regular lens can be made thinner by edge-bonding, or bonding the haptic to the outside of the lens as disclosed herein rather then burrowing a hole into the side of the lens as is done routinely.
- the lens optic 200 may be made of the same material as the film frame haptic 110 and can be made of a material as low as 15 shore on the A scale.
- the lens optic 200 can be attached to the frame haptic 110 in a variety of ways.
- a preferred embodiment is shown in FIG. 2B , in which the optic includes eyelets 400 which permit attachment of the lens to the cleats 300 on the haptic.
- the cleat 300 is shaped in such a way that the eyelet 400 will not easily be detached. It is envisioned that the surgeon can attach the optic 200 to the haptic within the eye using a forceps.
- the haptic 110 is inserted into the very small opening and positioned in the eye as desired (see FIG. 5A-E ).
- the optic 200 is rolled or folded as needed and inserted into the eye with forceps and attached to the furthest cleat 300 from the opening ( FIGS. 5F and G). As the forceps are removed, the eyelet 400 on the other side of the optic 200 can be attached to the cleat 300 closest to the opening ( FIG. 5H ).
- the optic 200 is produced of a material with a lower modulus then the haptic 110 , thus allowing the eyelet to be slightly stretched as the haptic is slightly sprung to allow a stronger attachment of the optic eyelets 400 to the cleats 300 on the haptic 110 .
- one side of the optic 200 can be fastened before insertion of the IOL 10 into the eye.
- the optics of this invention can be made with very thin edges (as thin or as low as 10 ⁇ ) to help reduce edge glare.
- the cleats 300 may be arranged such that they are not diametrically opposed.
- An advantage of this is that lenses can be used which are not symmetrical, allowing for treatment of astigmatism. For example if a lens needs to be inserted and positioned in a specific orientation, it can be more easily done with this asymmetry as a visual aid.
- multifocal optics can be used which allow for correction of a variety of eyesight imperfections.
- the addition of a third cleat 300 would allow control of asymmetric as well as symetric features.
- the cleats 300 of the invention have been shown to work particularly well for the intended purpose. Therefore it is envisioned that they could be used to attach any type of IOL before insertion or after insertion. In addition, they would allow the surgeon a choice of lenses or powers to insert and the surgeon could potentially clip one or more lenses onto the cleat 300 . A further aid to the surgeon would be to tint the cleats 300 and/or eyelets 400 such that they would be more visually identifiable to the surgeon during the operation.
- the film frame haptics 110 and feet 121 are preferably manufactured from a high modulus material.
- High modulus materials are generally relatively stiff, or hard, but springy and permit relatively little elongation before they break. Such materials are often brittle and have a high permanent set, but retain their shape after formation.
- the high modulus material is a biocompatible thermoplastic film such as polyimide, polyetheretherketolle, polycarbonate, polymethylpentene, polymethylmethyl methacrylate, polypropylene, polyvinylidene fluoride, polysulfone, and polyether or polyphenyl sulfone. These are often referred to as “engineering plastics”.
- the frame 110 and feet 121 may be cut from a sheet by machining, stamping, chemical machining, water jet machining or photomachining with an excimer or YAG laser.
- the sheet material may also be punch stamped, perforated, photochemically or photo-optically shaped.
- An alternative method for production of the film frame 110 includes molding the high modulus material into the desired shape. It is generally known in the plastics art to identify thin sheets of plastics less than 0.010 inches thick as “films”, that definition is used herein.
- the eyelet aperture hole is about 0.1 mm to 1.2 mm, preferably 0.5 mm.
- the thickness can be 0.001 to 0.010 inches, preferably 0.002 to 0.003 inches.
- the arcuate vaulting curves and shapes are secondarily formed into the haptic by mounting the frame on a dihedral shaped tool or equivalent and baked in an oven between 150° F. up to 550° F. depending on the haptic machine requirements.
- the film frame haptic 110 is typically next polished to remove any rough edges.
- the preferred method of polishing involves abrasive tumble agitation polishing with glass beads.
- An alternative method for polishing the film frame haptic 110 and feet 121 includes flame polishing. At least the areas of the film frame or haptic 110 away from the optic region, which are to be hinges, are then treated such that an elastomeric compound can be attached.
- An alternative surface treatment includes plasma (a low pressure corona treatment) treating. Alternatively, the entire frame 110 could be surface treated or primed. Additionally, surface roughening such as by grit or vapor blasting can be included.
- the frame haptic 110 is polyphenylsulfone which has a tensile modulus of about 340,000 psi (using test method D 638 of the ASTM) and is clear but exhibits a natural UV light absorbence property below 400 nm's resulting in a yellowish or amber tint.
- the frame haptic 110 is preferably made from film which is generally ⁇ 0.025 cm (0.010 inches) thick, preferably 0.001 to 0.005 inches thick, but could be as thick as 0.012 inches or even as thin as 0.0005 inches.
- the feet 121 are identical, but, non-identical feet 121 configurations can be paired for use in an alternative embodiment when necessary.
- the thinness of the film frame haptic 110 contributes to its springiness and lightness which is advantageous in that the IOL is less likely to be disrupted from its initial position.
- the film lenses of these designs are typically about half the weight of a standard lens and can be between 2 to 10 milligrams and as low as 1 milligram in weight in air and about 10% of this when in the aqueous of the eye.
- the lens is flexible but may be made of a hard, stiff, low memory material.
- the lens is made of silicone and the chosen silicone can be as low as 15 shore A.
- the index (N) value would be 1.430 to 1.460.
- FIGS. 5A-E illustrate how the haptic can be manipulated through a very small incision without deformation. This is preferable to a haptic which may posses a hinge or be “foldable” because it requires no lateral movement or unfolding within the very narrow confines of the posterior chamber of the eye and which may contribute to damage within the eye.
- the “L”-shaped haptic allows for insertion through a very small incision 500 by rotating the haptic as it is manipulated and moved into the eye 1 .
- the dimensions of the haptic are such that the greatest cross-sectional dimension at any point along the haptic is less than 2 mm.
- FIG. 5A shows the haptic initially being inserted into the incision starting at the short arm of the “L” up to the “corner” 122 .
- the haptic is manipulated such that the “corner” is inserted and the haptic is rotated ( 5 C) until the short arm of the haptic lines up with the edge of the eye and the long arm is about perpendicular to the incision.
- the long arm is inserted by pushing the haptic straight in ( 5 D).
- the last step may require a slight axial shortening of the haptic by slightly springing it inwardly to be fully inserted into the eye 1 .
- Such springing is distinguished from the distortions, such as folding bending or rolling, normally used to introduce an intraocular lens into the eye. It can be envisioned that a number of different “L” shapes could be used to produce such a haptic. FIG. 6A-C shows three other examples of the “L” shape.
- the optic 200 is rolled or folded as needed and inserted into the eye with forceps and attached to the furthest cleat 300 from the opening ( FIGS. 5F and G). As the forceps are removed, the eyelet 400 on the other side of the optic 200 can be attached to the cleat 300 closest to the opening ( FIG. 5H ).
- the film frame/haptic 110 comprises three areas which come in contact with the eye tissue.
- the feet 121 and toes 150 function like plate haptics and, as such, differ from the fiber haptics of the prior art.
- the hinged “toe” 150 is attached to the foot so that will easily pivot to adjust into a better fit while maintaining lens centration.
- the feet 121 include a hinge region 120 .
- the hinge region 120 permits each toe 150 to have a relaxed position which can be at a slight angle to the plane of the film frame 110 and the rest of the foot 121 . This slight angle permits each foot 121 to fit into the posterior chamber in such a way that the IOL 10 will be gently secured using the low mechanical loads produced by the flexible hinge region 120 combined with the flexible frame.
- the flexible frame can additionally be arcuately curved or shaped with a dihedral angle to more closely approximate the eye shape. More specifically, the toe region 150 is preferably made up of a loop 126 (see FIG.
- loop 126 such that one end of the loop 126 , or slotted region, is spaced from the foot 121 to form an opening 122 .
- the other end of the loop 126 is attached to the foot 121 by a notched or thinned region 123 , which temporarily supports the loop 126 in place during fabrication.
- the hinge regions 120 are treated in such a way that a lower modulus material can be coated onto the higher modulus material completely, or partially to connect the toe 150 and foot 121 regions as explained above.
- the coating for the hinge 120 and toe 150 is made from an elastomeric material which has a lower modulus (rubbery) than that of the harder film frame haptic 110 .
- a low modulus or softer material has high elongation and high memory to urge the toe back into its original position when compressed and is preferably snappy like laytex surgeons gloves.
- the more rigid frame haptic 110 provides the conforming shape while the elastamer provides a resilient hinge 120 , similar to a person's feet and toes.
- a rubbery hinge connecting rigid frame members functions, such that, when bent, the outer rubbery surface is tensioned and the inner rubbery surface is compressed.
- a variety of biocompatable elastomers such as urethanes and silicone dispersions such as NUSIL MED 6605, 6400, or 6820 can be used as elastomers for the hinge 120 covering.
- the high modulus material can be surface treated using corona, plasma, or primers, individually or in combination. Next a primer is applied and lastly, the elastomer or low modulus material can be added by dipping at least each foot 121 into the coating and subsequently curing it.
- the low modulus material is mechanically attached or chemically attached, and may be applied by cast molding as well as injection molding.
- the process can be repeated.
- the hinge region 120 and foot region 121 are dip coated multiple times with a dispersion, dispersions contain solvents that evaporate leaving behind thinner coatings so that the thickness would be less than is would be if the dispersion were not in a solvent.
- alternative embodiments do not require multiple dipping.
- a protocol for the coating process is included in Example 1.
- the hinge regions 120 may be produced by breaking the high modulus material at the hinges 120 , scores, or notches. This may be done by flexing the region until the high modulus material work hardens and breaks. Alternatively, the hinge region may not need to be broken.
- the dimensions included in FIG. 7 are illustrative of the size of the various elements of the preferred haptic.
- FIGS. 8A-H Alternative embodiments of the invention are shown in FIGS. 8A-H .
- an IOL is shown which possesses three attachments.
- the lens 200 possesses three eyelets 400 of various sizes and shapes.
- the angles of the eyelets 400 within the lens can be the same or different. This provides for angular non-symmetry.
- FIG. 8B is an alternative which has the cleats 300 on the lens 200 and the slots, eyelets, apertures or notches 400 on the haptic 110 .
- the lens is attached by pulling the ears of the cleat 300 through the slots 400 .
- FIG. 8C is an alternative embodiment showing one long cleat 300 and one long slot 400 .
- the lens may have one or more additional tabs for stability.
- FIGS. 8 D 1 and 2 show an embodiment of the multi-part IOL in which the lens is attached with a very stretchable eyelet 400 at at least one attachment site, such that the haptic can be inserted as in FIGS. 5A-E with the lens remaining outside of the incision.
- the eyelet 400 may elongate up to 300% its length (see FIG. 8 D 2 ).
- the lens 200 can also include a second eyelet 400 or tab which provides more stability to the lens 200 on the haptic 110 .
- the eyelet 400 may alternatively have a sidways hole (see FIG. 8 D 2 ).
- FIG. 8E shows a further alternative embodiment in which the optic 200 has a single large eyelet 400 which forms a stretchable band and may be as wide as the lens.
- the eyelet 400 can stretch away from the rigid frame during manipulation during implant of the IOL. Once it springs back into position, a slight outward tension holds the lens 200 flat.
- the haptic 110 has two notches with which the eyelet 400 attaches at two separate points to hold the lens flat with a slight outward tension.
- IOL's are fabricated with only one eyelet. Since the weight of an optic in an aqueous solution, such as that in the eye, is significantly reduced in the aqueous of the eye, the buoyant effects produce a weight of only 1/10 of that in air. So the single eyelet serves more as a positional support then a weight support.
- the lenses In most previous IOL's, the lenses have predominantly been round. However, it can be envisioned that the lens can be of many shapes. For example, in FIG. 8F , the lens is oval, which would advantageously make the IOL narrower. In FIG. 8G the lens is segmented or chopped at one side to reduce the overall width of the IOL. In FIG. 8H the optic has a parallelogram shape or even a trapezoid shape again allowing for a reduction in overall width. In this case the IOL may have up to four eyelets or even up to six.
- a 2 mm incision is made near the limbus of the eye. Buffers are injected into the anterior chamber.
- the frame is inserted as shown in FIGS. 5A-H by a rotation action.
- the surgeon grasps the folded optic with the outside (distal) eyelet leading forward.
- the surgeon then pushes the lens through the incision and hooks the distal eyelet onto the distal cleat of the frame.
- the surgeon slowly opens the forceps while maintaining slight tension.
- the lens is then grasped near or onto the closest eyelet (proximal) and pulls it over the closer cleat of the frame.
- the IOL of the present invention presents a number of advantages. It is inserted in two separate pieces significantly reducing the bulk so that the incision can be as narrow as 1 mm. It is lightweight and thin which reduces corneal chafing and pupilary block. In addition, because of the hinges and toes and arcuate shape, it is capable of being inserted and resting on the anterior chamber angle with a minimum of damage to the tissues as well as a minimum of discomfort to the patient. The fact that it is a plate haptic shape eliminates the problem of synechiae, and it can be used in a phakic or aphakic eye.
- the lens is a multi-part assembly, the ideal properties of each part of the IOL can be retained.
- the haptic is ideally more rigidly springy and can be constructed to fit into a very narrow incision without deformation.
- the lens although it is between 4 mm and 7 mm, can be inserted into a narrow incision because it is constructed of a more pliable and soft material and can be folded, squeezed or rolled, more than it could be with the attached haptic, to be inserted into a considerably smaller incision. Therefore a multi-part IOL allows for insertion into a much narrower incision, than an assembled lens.
- the lens can be implanted into the eye using a variety of surgical implant techniques known in the art. Although the preferred embodiment is that the lens be implanted into the anterior chamber, using the anterior chamber angles, it can be envisioned that the lens could also be implanted in the posterior chamber.
- any combination of the materials used will result in a lens that can be sterilized by a variety of standard methods such as ethylene oxide (ETO) or steam autoclaving at 250° F. or any other acceptable method and the lens will show long term biocompatablity and hydrolytic stability.
- ETO ethylene oxide
- steam autoclaving at 250° F. or any other acceptable method and the lens will show long term biocompatablity and hydrolytic stability.
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- Executing Machine-Instructions (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Electrophonic Musical Instruments (AREA)
Abstract
An intraocular lens device including a foldable lens optic configured to fit through a small incision in the eye connected to a lens frame haptic configured to fit separately through a small incision in the eye.
Description
- The present invention generally relates to a two part “L”-shaped IOL. More specifically, the present invention relates to an IOL film frame which is insertable through an opening as small as 1.0 mm without deforming the frame and a lens which can then be attached within the eye.
- The history of intraocular lenses (IOLs) is a long and varied one. Intraocular lenses can be used to treat a wide diversity of eye conditions ranging from cataracts to any type of eyesight correction. In addition, IOLs can be used to replace an irreversibly damaged lens in the eye—aphakic eyes. Alternatively, the lenses can be used in addition to the natural lens to correct the vision—phakic eyes. These lenses can be placed in the anterior or posterior chambers of the eye.
- Early IOL researchers were plagued with problems associated with the materials which were obtainable to them at the time (early 1950's) making the lenses too heavy and too large. Surgery of the eye was in its infancy and therefore there were many problems with the surgical procedures. Since that time the quality, size and weight of the optics as well as microsurgical procedures have dramatically improved.
- The earliest IOL's were placed in the anterior chamber of the eye, this being the easiest chamber to get to. Along with the early problems with the optics and surgical techniques, placement of a lens in the anterior chamber proved difficult because the anterior chamber is narrow (about 1.5 to 2.5 mm).
- The second location is the angle between the cornea and the iris. Angle supported anterior chamber IOLs took advantage of the anterior chamber angle to support and fix the IOL in place. By angling the IOL into opposite sides of the anterior chamber, the natural angle was used to keep the IOL from moving. However, early lenses experienced marked problems with endothelial loss due to chafing against the early thick lenses. Later lenses were able to reduce the significance of this problem, but still retained problems associated with placement of the IOL in the chamber angle. The biological properties of that angle make it a very sensitive area. The structures associated with equalizing the internal pressure of the eye are located in that area. Additionally, the tissue in the area is easily irritated and irritation initiates a growth of fibrous tissue, called synechiae. The IOL fixation must be gentle in order to reduce irritation, but stable enough that it will not be easily moveable. This compromise is difficult to obtain. In addition, although the results were excellent in the short-term, there was a significant problem in the long term with altered night vision, loss of endothelial cell populations and alteration of the anterior uvea. These problems as well as the fact that such anteriorly positioned lenses were uncomfortable to the patient, caused many doctors to abandon anterior chamber IOL's.
- A third location was developed later and involves implanting a contact lens between the iris and the natural lens. These lenses are called ICL's or implantable contact lenses. However, the ICL's are suspected of initiating cataracts and glaucoma.
- As the development of the IOL's became more sophisticated, Ophthalmologists recognized various problems. A typical IOL is composed of an optic, the ‘lens’ part of the structure, and a mounting mechanism called a haptic. The haptics are the part of the IOL that comes in contact with the eye tissue to hold the lens optic in place. There were essentially two major types of haptics which were developed—fiber and plate haptics. Fiber haptics are slender strands of resilient material which are attached at one end to the optic, and which rest, at their other end, against the eye. Fiber haptics have the advantage of being very light and slender. This would seem to make them ideal by causing less damage to the tissue and additionally being aesthetically pleasing because they are very narrow. The slenderness makes it more difficult for someone looking at the patient to see the IOL through the eye. Plate haptics are machined or molded from stock materials and have a central optic and an outer perimeter which rests against the eye. Because of their size, plate haptics tend to be more easily seen from outside in the patient's eye and the addition of extra material weight to the IOL and reduced flexibility as compared to fiber haptics leads to poor fixation and consequent migration or dislocation of the IOL. While, fiber haptics have the disadvantage of initiating a process in which the body builds fibrous tissue or synechiae around the fiber haptic which immobilizes the iris, the larger plate haptic very rarely, if ever, causes such a reaction.
- The adverse problems associated with the earlier anterior chamber haptic designs encouraged the development of IOL's for the posterior chamber for the majority of implants.
- The surgical process may or may not include removal of the diseased natural lens using a process called phakoemulsification. The more standardized procedure for lens implantation involves removal of a diseased natural lens followed by implantation of an artificial lens. Phakoemulsification of the diseased lens is accomplished through about a 2 to 4 mm (small) incision in the eye and through a capsulorhexis incision in the capsule that encloses the lens in the posterior chamber, then an artificial intraocular lens implant is implanted back through the capsulorhexus into the capsular bag. For other types of procedures, the natural lens may not require removal at all.
- As surgical procedures have developed, there is a trend toward reducing the size of the incision in the eye. Although a 3 mm incision does not usually require sutures for healing, it increases the chances of infection, heals slower, and may provide for a slower operation then if an incision of less than 3 mm is used. However, presently IOLs cannot be inserted into a very small incision, as small as 1 mm.
- Accordingly, an intraocular lens (IOL) has been developed. The intraocular lens features an optic and a haptic. The haptic is “V”-shaped and features relatively more rigid elements formed of relatively higher modulus (harder) materials which are flexibly springy when thin. The haptics may also comprise less rigid elements formed of relatively lower modulus (softer) materials bridging a discontinuity separating the haptics. The “V”-shaped haptic allows for insertion of the haptic through an opening in the eye as small as about 1 mm without deforming the frame. The haptic also features a fastening structure for the separate optic, preferably a cleat. The foldable optic is then inserted into the eye through the same ultra small incision and attached to the haptic, preferably the haptic cleat, by way of a formed aperture or eyelet in the optic.
- The higher modulus springy polymeric material may be selected from polyimide, polyetheretherketone, polycarbonate, polymethylpentene, polymethylmethyl methacrylate, polypropylene, polyvinylidene fluoride, polysulfone, and polyether sulfone. Preferably, the higher modulus material is polyphenylsulfone (PPSU). Preferably, the higher modulus material has a modulus of elasticity of about 100,000 to about 500,000 psi, even more preferably about 340,000 psi and has a hardness of about 60 to 95 on the shore D scale, but more specifically a Rockwell R hardness of 120 to 130. The lower modulus rubbery material may be an elastomer selected from silicones, urethane, or hydrophilic acrylics. Preferably, the lower modulus elastomeric material has a modulus of about 100 to about 1000 psi (unit load at 300% elongation). Preferably, lower modulus material has a hardness of about 15 to 70 on the shore A scale of hardness. Preferably, the lower modulus material is a dispersion such as NUSIL MED 6605, 6400, 6820, 6604, and 6607, or the like.
- In one embodiment, the relatively more rigid elements comprises a “V”-shaped frame. The frame forms three haptics which may be formed from a single uniform piece of material. The haptic may contain a cleat for attachment of the lens. The haptic may additionally contain a slot open on one side to form a hinge which is bendable at the slot. The haptic may alternatively contain a groove to form a hinge which is bendable at the groove.
- The lower modulus material may partially or completely cover the haptics. In one embodiment, the lower modulus material is extended beyond the tip of the haptic to produce a softer contact point for the eye tissue. The lower modulus material may be applied by first surface treating the higher modulus material and then molding the lower modulus material onto the treated surface. Preferably, the surface treatment is a corona or plasma treatment and additionally a primer. Preferably, the molding is dip molding, cast molding, or injection molding. Primers such as Nusil Med may also be used singly or in combination.
- The invention is a “V”-shaped intraocular lens frame, having multiple plate haptic elements preferably formed of relatively higher modulus harder material and containing an attachment for a separate optic.
- The invention may optionally have a hinge connecting the toe region to the foot region, the hinge being formed of relatively lower modulus material. This can be referred to as a “duplex” material.
- The optic may be any type of lens. Preferably, the optic is a refractive lens, or an interference lens, producing a thin optic. The optic could be toric, aspheric, multi-element, positive or negative.
- Further, the invention is an intraocular lens having an optic; and a haptic including stiffer elements joined by flexible elements of different materials.
- Still further, the invention is a method for making an intraocular lens haptic, having the steps of forming a frame, coating a location of the frame, and breaking the frame at the location.
- Still further, the invention is a method of mounting a lens in the anterior chamber of an eye, having the steps of supporting a lens on a plate haptic at the angle of the anterior chamber; and bending the haptic at a preferential hinge line to reduce pressure against the angle.
-
FIG. 1 is a simplified representation of the cross-sectional physiology of the eye with an anterior IOL in accordance with the preferred embodiment implanted. -
FIG. 2A is a plan view of the multi-part IOL in accordance with the preferred embodiment within the eye. -
FIG. 2B is a plan view of an alternate embodiment of the positioning of the cleat in accordance with the preferred embodiment. -
FIG. 2C is a side view of the multi-part IOL in accordance with the preferred embodiment. -
FIG. 3 is a plan view of the haptic in accordance with the preferred embodiment. -
FIGS. 4A-C are plan and side views of the cleat and eyelet used to attach the ocular onto the haptic. -
FIG. 5A-H is a plan view of the haptic and lens being inserted into an eye through an ultra-small incision. The arrows indicate which way the haptic is moved to allow insertion without deformation. -
FIGS. 6A-C are plan views of alternative “L”shapes for the haptic of the invention. -
FIG. 7 is a plan view of a preferred embodiment of the haptic containing hinged feet. -
FIG. 8A-H are plan views of alternative embodiments of the invention. - Accordingly, a haptic in the form of a “V”-shape has been developed for a two part IOL. This thin film frame haptic is insertable through an opening in the eye as small as about 1 mm without deformation of the haptic. This film frame haptic is also lightweight, springy and non-irritating, low cost, surgically implantable with a minimum of trauma to the eye, aesthetically pleasing, and does not support fibrous tissue growth. This IOL works in the anterior or posterior chamber of the eye for phakic or aphakic lenses. This haptic additionally comprises a fastener for a separate optic.
- This “V”-shaped IOL film frame is a haptic system based on a high modulus, shaped skeletal frame or plate haptic. The haptic system may optionally be assembled with low modulus, soft, elastomeric hinged zones. The more rigid frame or haptic in combination with the soft hinges ensures that the lens and haptic assembly will maintain its shape and stay ideally situated in the anterior chamber angle of the eye or in the posterior chamber. Whereas, a haptic of a single soft material will not maintain a desirable shape and will be more noodle-like in its spirit, the compliant hinge can automatically adjust to the normal movements of an eye.
- Referring to
FIG. 1 , thecornea 12 serves as a refracting medium in addition to its function as the anterior wall of the eye 1. Thepupil 14 and theiris 15 of variable aperture are located behind thecornea 12 and divide the eye 1 into ananterior chamber 16 and aposterior chamber 18. The naturalcrystalline lens 30 is connected by zonular fibers to a peripheral muscle about thelens 30 known as theciliary muscle 20. - The more standardized procedure for the removal of a diseased
natural lens 30 followed by implantation of an artificial lens involves the phakoemulsification of the diseased lens through a small incision in the eye and through a capsulorllexis incision in the capsule that encloses the lens in theposterior chamber 18, then an artificial intraocular lens implant is implanted back through the capsulorhexus into the capsular bag. For other types of procedures, thenatural lens 30 may not require removal at all. Theoptic 200 of theIOL 10 used in these procedures includes a separate centrally located optical zone and may be configured for implantation into either the anterior 16 orposterior chamber 18 and may be used for either procedure set out above. The haptic 110 of theIOL 10 extends radially outwardly in the general plane of the optic 200. - With reference now to
FIGS. 2 and 3 , the multi-part IOL arranged and configured in accordance with certain features, aspects and advantages of the present invention will be described in detail.FIGS. 2 and 3 are plan views of the film frame haptic of aplural part IOL 10 in accordance with the preferred embodiment. Theintraocular lens 10 is generally comprised of alens optic 200 and a lens frame haptic 110. The film frame haptic 110 includes threefeet 121 and two cross bars 190. The threefeet 121 and twocross bars 121 are arranged in an approximately “L”-shape. By “L” shape, it is envisioned that there is at least one “corner” or “angle” 122 which is as great as 135° or more, but preferably at about a 90° angle or less, preferably between 35 and 60° (angular degrees) and more preferably about 45°. This arrangement allows the haptic to be inserted into a very small incision without deformation of the haptic. The very small incision is preferably less than 3 mm, more preferably less than 2 mm, and even more preferably less than 1.5 nm and most preferably less than about 1.0 mm. The maximum dimension across the width of the haptic 110, at all points, is less than the incision. It is understood that, due to the fact that living tissue is very elastic and will yield a little, the incision in the eye can be stretched without damage to the tissue. For example, it has been observed that a 2.5 mm incision can be stretched to as much as 3 mm, to allow passage of a 3 mm wide haptic arm. - In a preferred embodiment, each
foot 121 may have ahinge region 120 which can be configured in a number of ways, but has the property of being more elastic than the main body of thefoot 121. Thishinge region 120 is formed of a material which is more elastic than the remainder of the lens frame haptic 110. In the preferred embodiment, thehinge region 120 is covered in anelastomeric material 127 which extends between thefoot 121 andtoe 150. Thehinge zone 120 can be a thinner section in the frame, or a discontinuous opening in the frame where theelastomer 127 extends between thefoot zone 121 and thetoe portion 150. Thehinge 120 andtoe 150 can be produced in a variety of ways which are described in detail in application Ser. No. 09/______, filed May 12, 2000. - With further reference to
FIGS. 2B and 3 , theseparate lens optic 200 can be any type of lens, elastomeric or polymeric optical material. The optic 200 can be a simple refractive lens, a monofocal, toric or aspheric, a bifocal, an interference lens, a positive lens or a negative lens. The lens can be made thinner by using the polychromatic diffractive lens disclosed in U.S. Pat. No. 5,589,982 which is hereby incorporated herein by reference. Optionally a regular lens can be made thinner by edge-bonding, or bonding the haptic to the outside of the lens as disclosed herein rather then burrowing a hole into the side of the lens as is done routinely. Thelens optic 200 can be made of silicone (Optical index N=1.40 to 1.46), soft acrylic (N=1.40 to 1.46), hydrophilic acrylic, or methyl methacrylate (N=1.49) or polyphenylsulfone (N=1.67). Alternatively, thelens optic 200 may be made of the same material as the film frame haptic 110 and can be made of a material as low as 15 shore on the A scale. - The
lens optic 200 can be attached to the frame haptic 110 in a variety of ways. A preferred embodiment is shown inFIG. 2B , in which the optic includeseyelets 400 which permit attachment of the lens to thecleats 300 on the haptic. in one embodiment, shown inFIG. 4 , thecleat 300 is shaped in such a way that theeyelet 400 will not easily be detached. It is envisioned that the surgeon can attach the optic 200 to the haptic within the eye using a forceps. The haptic 110 is inserted into the very small opening and positioned in the eye as desired (seeFIG. 5A-E ). Then the optic 200 is rolled or folded as needed and inserted into the eye with forceps and attached to thefurthest cleat 300 from the opening (FIGS. 5F and G). As the forceps are removed, theeyelet 400 on the other side of the optic 200 can be attached to thecleat 300 closest to the opening (FIG. 5H ). In a preferred embodiment, the optic 200 is produced of a material with a lower modulus then the haptic 110, thus allowing the eyelet to be slightly stretched as the haptic is slightly sprung to allow a stronger attachment of theoptic eyelets 400 to thecleats 300 on the haptic 110. In one embodiment it is envisioned that one side of the optic 200 can be fastened before insertion of theIOL 10 into the eye. The optics of this invention can be made with very thin edges (as thin or as low as 10μ) to help reduce edge glare. - With reference to
FIG. 2A it can be seen that thecleats 300 may be arranged such that they are not diametrically opposed. An advantage of this is that lenses can be used which are not symmetrical, allowing for treatment of astigmatism. For example if a lens needs to be inserted and positioned in a specific orientation, it can be more easily done with this asymmetry as a visual aid. In addition, multifocal optics can be used which allow for correction of a variety of eyesight imperfections. The addition of athird cleat 300 would allow control of asymmetric as well as symetric features. - The
cleats 300 of the invention have been shown to work particularly well for the intended purpose. Therefore it is envisioned that they could be used to attach any type of IOL before insertion or after insertion. In addition, they would allow the surgeon a choice of lenses or powers to insert and the surgeon could potentially clip one or more lenses onto thecleat 300. A further aid to the surgeon would be to tint thecleats 300 and/oreyelets 400 such that they would be more visually identifiable to the surgeon during the operation. - With reference to
FIG. 2B , the film frame haptics 110 andfeet 121 are preferably manufactured from a high modulus material. High modulus materials are generally relatively stiff, or hard, but springy and permit relatively little elongation before they break. Such materials are often brittle and have a high permanent set, but retain their shape after formation. Preferably, the high modulus material is a biocompatible thermoplastic film such as polyimide, polyetheretherketolle, polycarbonate, polymethylpentene, polymethylmethyl methacrylate, polypropylene, polyvinylidene fluoride, polysulfone, and polyether or polyphenyl sulfone. These are often referred to as “engineering plastics”. They have high tensile strength and are biocompatible, hydrolytically stable, and autoclavable for sterility, and have a high modulus ranging from a tensile modulus of about 100,000 to 500,000 psi (using test method D 638 of the ASTM). The material can be clear, opaque, or tinted, but is preferably clear. However, in many cases, even a tinted material, if produced thinly enough, will appear clear in the eye. Theframe 110 andfeet 121 may be cut from a sheet by machining, stamping, chemical machining, water jet machining or photomachining with an excimer or YAG laser. The sheet material may also be punch stamped, perforated, photochemically or photo-optically shaped. An alternative method for production of thefilm frame 110 includes molding the high modulus material into the desired shape. It is generally known in the plastics art to identify thin sheets of plastics less than 0.010 inches thick as “films”, that definition is used herein. The eyelet aperture hole is about 0.1 mm to 1.2 mm, preferably 0.5 mm. The thickness can be 0.001 to 0.010 inches, preferably 0.002 to 0.003 inches. - After photo-cutting, the arcuate vaulting curves and shapes are secondarily formed into the haptic by mounting the frame on a dihedral shaped tool or equivalent and baked in an oven between 150° F. up to 550° F. depending on the haptic machine requirements.
- The film frame haptic 110 is typically next polished to remove any rough edges. The preferred method of polishing involves abrasive tumble agitation polishing with glass beads. An alternative method for polishing the film frame haptic 110 and
feet 121 includes flame polishing. At least the areas of the film frame or haptic 110 away from the optic region, which are to be hinges, are then treated such that an elastomeric compound can be attached. An alternative surface treatment includes plasma (a low pressure corona treatment) treating. Alternatively, theentire frame 110 could be surface treated or primed. Additionally, surface roughening such as by grit or vapor blasting can be included. - In the preferred embodiment, the frame haptic 110 is polyphenylsulfone which has a tensile modulus of about 340,000 psi (using test method D 638 of the ASTM) and is clear but exhibits a natural UV light absorbence property below 400 nm's resulting in a yellowish or amber tint. The frame haptic 110 is preferably made from film which is generally ≦0.025 cm (0.010 inches) thick, preferably 0.001 to 0.005 inches thick, but could be as thick as 0.012 inches or even as thin as 0.0005 inches. In the preferred embodiment the
feet 121 are identical, but,non-identical feet 121 configurations can be paired for use in an alternative embodiment when necessary. The thinness of the film frame haptic 110 contributes to its springiness and lightness which is advantageous in that the IOL is less likely to be disrupted from its initial position. - The film lenses of these designs are typically about half the weight of a standard lens and can be between 2 to 10 milligrams and as low as 1 milligram in weight in air and about 10% of this when in the aqueous of the eye. Preferably the lens is flexible but may be made of a hard, stiff, low memory material. However, in the preferred embodiment, the lens is made of silicone and the chosen silicone can be as low as 15 shore A. The index (N) value would be 1.430 to 1.460.
-
FIGS. 5A-E illustrate how the haptic can be manipulated through a very small incision without deformation. This is preferable to a haptic which may posses a hinge or be “foldable” because it requires no lateral movement or unfolding within the very narrow confines of the posterior chamber of the eye and which may contribute to damage within the eye. InFIG. 5A-E , the “L”-shaped haptic allows for insertion through a verysmall incision 500 by rotating the haptic as it is manipulated and moved into the eye 1. The dimensions of the haptic are such that the greatest cross-sectional dimension at any point along the haptic is less than 2 mm.FIG. 5A shows the haptic initially being inserted into the incision starting at the short arm of the “L” up to the “corner” 122. At this point (FIG. 5B ) the haptic is manipulated such that the “corner” is inserted and the haptic is rotated (5C) until the short arm of the haptic lines up with the edge of the eye and the long arm is about perpendicular to the incision. The long arm is inserted by pushing the haptic straight in (5D). Because of the position of the incision in the eye, the last step (FIG. 5F ) may require a slight axial shortening of the haptic by slightly springing it inwardly to be fully inserted into the eye 1. Such springing is distinguished from the distortions, such as folding bending or rolling, normally used to introduce an intraocular lens into the eye. It can be envisioned that a number of different “L” shapes could be used to produce such a haptic.FIG. 6A-C shows three other examples of the “L” shape. - After the haptic 110 is inserted into the very small opening and positioned in the eye as desired (see
FIG. 5A-E ), the optic 200 is rolled or folded as needed and inserted into the eye with forceps and attached to thefurthest cleat 300 from the opening (FIGS. 5F and G). As the forceps are removed, theeyelet 400 on the other side of the optic 200 can be attached to thecleat 300 closest to the opening (FIG. 5H ). - With reference to
FIG. 7 , the film frame/haptic 110 comprises three areas which come in contact with the eye tissue. Thefeet 121 andtoes 150 function like plate haptics and, as such, differ from the fiber haptics of the prior art. The hinged “toe” 150 is attached to the foot so that will easily pivot to adjust into a better fit while maintaining lens centration. - With continued reference to
FIG. 7 , thefeet 121 include ahinge region 120. Thehinge region 120 permits eachtoe 150 to have a relaxed position which can be at a slight angle to the plane of thefilm frame 110 and the rest of thefoot 121. This slight angle permits eachfoot 121 to fit into the posterior chamber in such a way that theIOL 10 will be gently secured using the low mechanical loads produced by theflexible hinge region 120 combined with the flexible frame. The flexible frame can additionally be arcuately curved or shaped with a dihedral angle to more closely approximate the eye shape. More specifically, thetoe region 150 is preferably made up of a loop 126 (seeFIG. 2B ), such that one end of theloop 126, or slotted region, is spaced from thefoot 121 to form anopening 122. The other end of theloop 126 is attached to thefoot 121 by a notched or thinnedregion 123, which temporarily supports theloop 126 in place during fabrication. - With reference to
FIG. 7 , thehinge regions 120 are treated in such a way that a lower modulus material can be coated onto the higher modulus material completely, or partially to connect thetoe 150 andfoot 121 regions as explained above. The coating for thehinge 120 andtoe 150 is made from an elastomeric material which has a lower modulus (rubbery) than that of the harder film frame haptic 110. A low modulus or softer material has high elongation and high memory to urge the toe back into its original position when compressed and is preferably snappy like laytex surgeons gloves. The more rigid frame haptic 110 provides the conforming shape while the elastamer provides aresilient hinge 120, similar to a person's feet and toes. A rubbery hinge connecting rigid frame members functions, such that, when bent, the outer rubbery surface is tensioned and the inner rubbery surface is compressed. A variety of biocompatable elastomers such as urethanes and silicone dispersions such as NUSIL MED 6605, 6400, or 6820 can be used as elastomers for thehinge 120 covering. The high modulus material can be surface treated using corona, plasma, or primers, individually or in combination. Next a primer is applied and lastly, the elastomer or low modulus material can be added by dipping at least eachfoot 121 into the coating and subsequently curing it. The low modulus material is mechanically attached or chemically attached, and may be applied by cast molding as well as injection molding. In the preferred embodiment the process can be repeated. For example, thehinge region 120 andfoot region 121 are dip coated multiple times with a dispersion, dispersions contain solvents that evaporate leaving behind thinner coatings so that the thickness would be less than is would be if the dispersion were not in a solvent. However, alternative embodiments do not require multiple dipping. A protocol for the coating process is included in Example 1. - After coating, the
hinge regions 120 may be produced by breaking the high modulus material at thehinges 120, scores, or notches. This may be done by flexing the region until the high modulus material work hardens and breaks. Alternatively, the hinge region may not need to be broken. The dimensions included inFIG. 7 are illustrative of the size of the various elements of the preferred haptic. - Alternative embodiments of the invention are shown in
FIGS. 8A-H . InFIG. 8A an IOL is shown which possesses three attachments. Thelens 200 possesses threeeyelets 400 of various sizes and shapes. The angles of theeyelets 400 within the lens (α, β, and φ, σ and θ) can be the same or different. This provides for angular non-symmetry.FIG. 8B is an alternative which has thecleats 300 on thelens 200 and the slots, eyelets, apertures ornotches 400 on the haptic 110. The lens is attached by pulling the ears of thecleat 300 through theslots 400.FIG. 8C is an alternative embodiment showing onelong cleat 300 and onelong slot 400. The lens may have one or more additional tabs for stability. In this embodiment, thelens 200 can be pre-attached and rolled for insertion with the haptic much like the haptic inFIGS. 5A-E , however steps F-H would differ in that the lens would simply “unroll” once the haptic is in the correct position in the eye. FIGS. 8D1 and 2 show an embodiment of the multi-part IOL in which the lens is attached with a verystretchable eyelet 400 at at least one attachment site, such that the haptic can be inserted as inFIGS. 5A-E with the lens remaining outside of the incision. Theeyelet 400 may elongate up to 300% its length (see FIG. 8D2). Then, as a last step, the lens is rolled or folded, inserted into the incision, and allowed to pull or snap back to its starting position on the haptic 110. As shown in FIG. 8D2, thelens 200 can also include asecond eyelet 400 or tab which provides more stability to thelens 200 on the haptic 110. Theeyelet 400 may alternatively have a sidways hole (see FIG. 8D2).FIG. 8E shows a further alternative embodiment in which the optic 200 has a singlelarge eyelet 400 which forms a stretchable band and may be as wide as the lens. In this embodiment, theeyelet 400 can stretch away from the rigid frame during manipulation during implant of the IOL. Once it springs back into position, a slight outward tension holds thelens 200 flat. In this case the haptic 110 has two notches with which theeyelet 400 attaches at two separate points to hold the lens flat with a slight outward tension. Alternatively, IOL's are fabricated with only one eyelet. Since the weight of an optic in an aqueous solution, such as that in the eye, is significantly reduced in the aqueous of the eye, the buoyant effects produce a weight of only 1/10 of that in air. So the single eyelet serves more as a positional support then a weight support. - In most previous IOL's, the lenses have predominantly been round. However, it can be envisioned that the lens can be of many shapes. For example, in
FIG. 8F , the lens is oval, which would advantageously make the IOL narrower. InFIG. 8G the lens is segmented or chopped at one side to reduce the overall width of the IOL. InFIG. 8H the optic has a parallelogram shape or even a trapezoid shape again allowing for a reduction in overall width. In this case the IOL may have up to four eyelets or even up to six. - A 2 mm incision is made near the limbus of the eye. Buffers are injected into the anterior chamber. The frame is inserted as shown in
FIGS. 5A-H by a rotation action. The surgeon grasps the folded optic with the outside (distal) eyelet leading forward. The surgeon then pushes the lens through the incision and hooks the distal eyelet onto the distal cleat of the frame. Then, the surgeon slowly opens the forceps while maintaining slight tension. The lens is then grasped near or onto the closest eyelet (proximal) and pulls it over the closer cleat of the frame. - Therefore, the IOL of the present invention presents a number of advantages. It is inserted in two separate pieces significantly reducing the bulk so that the incision can be as narrow as 1 mm. It is lightweight and thin which reduces corneal chafing and pupilary block. In addition, because of the hinges and toes and arcuate shape, it is capable of being inserted and resting on the anterior chamber angle with a minimum of damage to the tissues as well as a minimum of discomfort to the patient. The fact that it is a plate haptic shape eliminates the problem of synechiae, and it can be used in a phakic or aphakic eye.
- One advantage of the present invention is that because the lens is a multi-part assembly, the ideal properties of each part of the IOL can be retained. For example, the haptic is ideally more rigidly springy and can be constructed to fit into a very narrow incision without deformation. The lens, although it is between 4 mm and 7 mm, can be inserted into a narrow incision because it is constructed of a more pliable and soft material and can be folded, squeezed or rolled, more than it could be with the attached haptic, to be inserted into a considerably smaller incision. Therefore a multi-part IOL allows for insertion into a much narrower incision, than an assembled lens.
- The lens can be implanted into the eye using a variety of surgical implant techniques known in the art. Although the preferred embodiment is that the lens be implanted into the anterior chamber, using the anterior chamber angles, it can be envisioned that the lens could also be implanted in the posterior chamber.
- Additionally, any combination of the materials used will result in a lens that can be sterilized by a variety of standard methods such as ethylene oxide (ETO) or steam autoclaving at 250° F. or any other acceptable method and the lens will show long term biocompatablity and hydrolytic stability.
- While this invention has been described with respect to various specific examples and embodiments, it is to be understood that the invention is not limited thereto and that it can be variously practiced within the scope of the following claims:
Claims (21)
1-45. (canceled)
46. An intraocular lens device for use in an eye, said intraocular lens device comprising:
a foldable lens optic configured to fit through a small incision in the eye;
a lens frame haptic configured to fit through a small incision in the eye, lens frame haptic connectable to said foldable lens optic, said lens frame haptic stretching said foldable lens optic under tension during assembly of said intraocular lens device, and then maintaining said foldable lens optic in an operational configuration in the eye.
47. An intraocular lens device for use in an eye, said intraocular lens device comprising:
a foldable lens optic configured to fit through a small incision in the eye, said lens optic including at least one eyelet;
a lens frame haptic configured to fit through a small incision in the eye, said lens frame haptic including at least one cleat cooperating with said eyelet of said lens optic for connecting said foldable lens optic to said lens frame haptic, said cleat placing said eyelet under tension while connecting said eyelet to said at least one cleat to anchor said lens optic to said lens frame haptic.
48. An intraocular lens device for use in an eye, said intraocular lens device comprising:
a foldable lens optic configured to fit through a small incision in the eye, said lens optic including at least one stretchable eyelet;
a lens frame haptic configured to fit through a small incision in the eye, said lens frame haptic including at least one cleat cooperating with said stretchable eyelet of said lens optic for connecting said foldable lens optic to said lens frame haptic, said lens frame haptic operating through said cleat for connecting and stretching said stretchable eyelet of said lens optic and placing said foldable lens optic under tension during assembly for securely connecting anchoring and maintaining said lens optic on said lens frame haptic during operation in the eye.
49. An intraocular lens device according to claim 46 , wherein said lens frame haptic maintains said lens optic under tension after assembly and use of said intraocular lens device.
50. An intraocular lens device according to claim 46 , wherein said lens optic includes at least one eyelet and said lens frame haptic includes at least one cleat, said eyelet and said cleat configured to cooperate together to connect said lens optic to said lens frame haptic.
51. An intraocular lens device according to claim 50 , wherein said eyelet is a stretchable eyelet, said lens frame haptic operating through said cleat connecting and stretching said stretchable eyelet and placing said foldable lens optic under tension for securely connecting and maintaining said lens optic to said lens frame haptic.
52. An intraocular lens device according to claim 50 , wherein said at least one eyelet is a pair of opposed eyelets provided in said lens optic.
53. An intraocular lens device according to claim 52 , wherein said at least one cleat is a pair of cleats located on said lens frame haptic each cooperating with one of said pair of opposed eyelets.
54. An intraocular lens device according to claim 53 , wherein said lens frame haptic includes two cross bars connected together at an angle, said pair of cleats each being located on one of said cross bars.
55. An intraocular lens device according to claim 46 , wherein said lens frame haptic is stiffer than said lens optic.
56. An intraocular lens device according to claim 55 , wherein lens frame haptic is flexibly springy.
57. An intraocular lens device according to claim 56 , wherein said lens frame haptic is made of a higher modulus springy polymeric material.
58. An intraocular lens device according to claim 57 , wherein said polymeric material is one selected from the group consisting of polyimide, polyetheretherketone, polycarbonate, polymethylpentene, polymethylmethylmethacrylate, polypropylene, polyvinylidene fluoride, polysulfone, and polyether sulfone.
59. An intraocular lens device according to claim 53 , wherein said lens frame haptic is V-shaped.
60. An intraocular lens device according to claim 53 , wherein said lens frame haptic is L-shaped.
61. An intraocular lens device according to claim 46 , wherein said lens optic includes at least one eyelet and said lens frame haptic includes at least one slot, said eyelet and said slot configured to cooperate together to connect said lens optic to said lens frame haptic.
62. An intraocular lens device according to claim 46 , wherein said lens optic is at least one selected from the group consisting of toric, aspheric, multi-element positive and negative.
63. An intraocular lens device according to claim 50 , wherein said eyelet is stetched open to attach said eyelet to said cleat within the eye and placed under tension to securely connect said lens optic to said lens frame haptic and maintain said lens optic connected to said lens frame haptic during use in the eye.
64. An intraocular lens device according to claim 46 , wherein said lens frame haptic is configured to be inserted through the small incision without being deformation.
65. An intraocular lens device according to claim 65 , wherein said lens frame haptic includes two cross bars connected together at an angle, and configured so that a end of one of said cross bars is first inserted through said small incision followed by inserting the other said cross bar.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/980,387 US20080125862A1 (en) | 2000-08-04 | 2007-10-31 | Two part "L" -shaped Phakic IOL |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/631,576 US7462194B1 (en) | 2000-08-04 | 2000-08-04 | Two part “L”-shaped phakic IOL |
US11/980,387 US20080125862A1 (en) | 2000-08-04 | 2007-10-31 | Two part "L" -shaped Phakic IOL |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/631,576 Continuation US7462194B1 (en) | 2000-08-04 | 2000-08-04 | Two part “L”-shaped phakic IOL |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080125862A1 true US20080125862A1 (en) | 2008-05-29 |
Family
ID=24531808
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/631,576 Expired - Fee Related US7462194B1 (en) | 2000-08-04 | 2000-08-04 | Two part “L”-shaped phakic IOL |
US11/980,387 Abandoned US20080125862A1 (en) | 2000-08-04 | 2007-10-31 | Two part "L" -shaped Phakic IOL |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/631,576 Expired - Fee Related US7462194B1 (en) | 2000-08-04 | 2000-08-04 | Two part “L”-shaped phakic IOL |
Country Status (8)
Country | Link |
---|---|
US (2) | US7462194B1 (en) |
EP (1) | EP1307164B1 (en) |
JP (1) | JP2004505667A (en) |
AT (1) | ATE342700T1 (en) |
AU (1) | AU2001277043A1 (en) |
CA (1) | CA2417966A1 (en) |
DE (1) | DE60123964D1 (en) |
WO (1) | WO2002011649A2 (en) |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100204790A1 (en) * | 2009-02-09 | 2010-08-12 | Whitsett Jeffrey C | Exchangeable intraocular lens device and method of use |
US20100286773A1 (en) * | 2008-10-15 | 2010-11-11 | Guangzhou Visbor Biotechnology Ltd. | Manufacturing method of foldable artificial vitreous body and mould thereof |
US20110238173A1 (en) * | 2005-04-14 | 2011-09-29 | Acufocus, Inc. | Ophthalmic devices having a degradation resistant polymer |
WO2011163559A1 (en) * | 2010-06-25 | 2011-12-29 | Elenza, Inc. | Implantable ophthalmic devices with circularly asymmetric optic and methods |
US8167941B2 (en) | 2008-01-03 | 2012-05-01 | Forsight Labs, Llc | Intraocular, accommodating lens and methods of use |
US8414646B2 (en) | 2007-12-27 | 2013-04-09 | Forsight Labs, Llc | Intraocular, accommodating lens and methods of use |
US8752958B2 (en) | 1999-03-01 | 2014-06-17 | Boston Innovative Optics, Inc. | System and method for increasing the depth of focus of the human eye |
WO2014190029A1 (en) * | 2013-05-21 | 2014-11-27 | Transcend Medical, Inc. | Flow promoting ocular implant device and methods |
US9005281B2 (en) | 2009-08-13 | 2015-04-14 | Acufocus, Inc. | Masked intraocular implants and lenses |
US9084662B2 (en) | 2006-01-17 | 2015-07-21 | Transcend Medical, Inc. | Drug delivery treatment device |
US9138142B2 (en) | 2003-05-28 | 2015-09-22 | Acufocus, Inc. | Masked intraocular devices |
US9204962B2 (en) | 2013-03-13 | 2015-12-08 | Acufocus, Inc. | In situ adjustable optical mask |
US9398977B2 (en) | 2006-01-17 | 2016-07-26 | Transcend Medical, Inc. | Glaucoma treatment device |
US9427922B2 (en) | 2013-03-14 | 2016-08-30 | Acufocus, Inc. | Process for manufacturing an intraocular lens with an embedded mask |
US9545303B2 (en) | 2011-12-02 | 2017-01-17 | Acufocus, Inc. | Ocular mask having selective spectral transmission |
US9814568B2 (en) | 2005-03-30 | 2017-11-14 | Forsight Vision6, Inc. | Accommodating intraocular lens having dual shape memory optical elements |
WO2017203517A1 (en) * | 2016-05-22 | 2017-11-30 | Joshua Ben Nun | Hybrid accommodating intraocular lens assemblages |
US9913712B2 (en) | 2011-02-04 | 2018-03-13 | Forsight Labs, Llc | Intraocular accommodating lens and methods of use |
US10285805B2 (en) | 2014-03-28 | 2019-05-14 | Forsight Labs, Llc | Accommodating intraocular lens |
US10912643B2 (en) | 2004-04-29 | 2021-02-09 | Forsight Vision6, Inc. | Accommodating intraocular lens assemblies and accommodation measurement implant |
US11523898B2 (en) | 2016-10-28 | 2022-12-13 | Forsight Vision6, Inc. | Accommodating intraocular lens and methods of implantation |
US12226309B2 (en) | 2013-03-15 | 2025-02-18 | Alcon Inc. | Intraocular lens storage and loading devices and methods of use |
US12303430B2 (en) | 2023-09-06 | 2025-05-20 | Alcon Inc. | Glaucoma treatment device |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6616691B1 (en) * | 2003-01-10 | 2003-09-09 | Alcon, Inc. | Accommodative intraocular lens |
US20080086208A1 (en) * | 2004-08-24 | 2008-04-10 | Nordan T Lee | Foldable Intraocular Lens With Adaptable Haptics |
US20070027541A1 (en) * | 2005-07-26 | 2007-02-01 | Visioncare Ophthalmic Technologies Inc. | Intraocular devices and methods for implantation thereof |
US8034107B2 (en) * | 2005-09-01 | 2011-10-11 | Stenger Donald C | Accommodating intraocular lens |
US10451897B2 (en) | 2011-03-18 | 2019-10-22 | Johnson & Johnson Vision Care, Inc. | Components with multiple energization elements for biomedical devices |
US8857983B2 (en) | 2012-01-26 | 2014-10-14 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lens assembly having an integrated antenna structure |
IL224797A (en) * | 2012-02-22 | 2017-03-30 | Johnson & Johnson Vision Care | Ophthalmic lens with segmented ring layers in a functionalized insert |
US10627651B2 (en) | 2014-08-21 | 2020-04-21 | Johnson & Johnson Vision Care, Inc. | Methods and apparatus to form biocompatible energization primary elements for biomedical devices with electroless sealing layers |
US10361405B2 (en) | 2014-08-21 | 2019-07-23 | Johnson & Johnson Vision Care, Inc. | Biomedical energization elements with polymer electrolytes |
US9793536B2 (en) | 2014-08-21 | 2017-10-17 | Johnson & Johnson Vision Care, Inc. | Pellet form cathode for use in a biocompatible battery |
US9941547B2 (en) | 2014-08-21 | 2018-04-10 | Johnson & Johnson Vision Care, Inc. | Biomedical energization elements with polymer electrolytes and cavity structures |
US9599842B2 (en) | 2014-08-21 | 2017-03-21 | Johnson & Johnson Vision Care, Inc. | Device and methods for sealing and encapsulation for biocompatible energization elements |
US10361404B2 (en) | 2014-08-21 | 2019-07-23 | Johnson & Johnson Vision Care, Inc. | Anodes for use in biocompatible energization elements |
US9715130B2 (en) | 2014-08-21 | 2017-07-25 | Johnson & Johnson Vision Care, Inc. | Methods and apparatus to form separators for biocompatible energization elements for biomedical devices |
US9383593B2 (en) | 2014-08-21 | 2016-07-05 | Johnson & Johnson Vision Care, Inc. | Methods to form biocompatible energization elements for biomedical devices comprising laminates and placed separators |
US10381687B2 (en) | 2014-08-21 | 2019-08-13 | Johnson & Johnson Vision Care, Inc. | Methods of forming biocompatible rechargable energization elements for biomedical devices |
US10345620B2 (en) | 2016-02-18 | 2019-07-09 | Johnson & Johnson Vision Care, Inc. | Methods and apparatus to form biocompatible energization elements incorporating fuel cells for biomedical devices |
EP4072776B1 (en) * | 2019-12-12 | 2023-12-27 | Benz Research And Development Corporation | Mandrel for holding a lens blank and method of making a lens using the same |
US11759309B2 (en) | 2020-04-29 | 2023-09-19 | Long Bridge Medical, Inc. | Devices to support and position an intraocular lens within the eye and methods of use |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4056855A (en) | 1976-04-07 | 1977-11-08 | Charles Kelman | Intraocular lens and method of implanting same |
US4092743A (en) | 1976-10-04 | 1978-06-06 | Kelman Charles D | Intraocular lenses |
US4268921A (en) | 1979-10-22 | 1981-05-26 | Kelman Charles D | Intraocular lenses |
US4370760A (en) | 1981-03-25 | 1983-02-01 | Kelman Charles D | Anterior chamber intraocular lens |
US4608049A (en) | 1982-06-28 | 1986-08-26 | Kelman Charles D | Intraocular lens and method of inserting an intraocular lens into an eye |
US4434515A (en) * | 1982-07-26 | 1984-03-06 | Lynell Medical Technology Inc. | Intraocular lens |
GB2171912A (en) | 1985-03-05 | 1986-09-10 | Charles William Simcoe | Hinged intraocular lens |
US4636210A (en) | 1985-12-09 | 1987-01-13 | Hoffer Kenneth J | Multi-part intraocular lens and method of implanting it in an eye |
DE3626869C2 (en) * | 1986-08-08 | 1994-06-09 | Adatomed Pharma & Med | Intraocular lens |
US4725276A (en) * | 1986-09-04 | 1988-02-16 | Precision-Cosmet Co., Inc. | Intraocular lens with continuous posterior ring-like member |
US4769035A (en) | 1987-06-02 | 1988-09-06 | Kelman Charles D | Artificial lens and the method for implanting such lens |
US4781718A (en) * | 1987-10-09 | 1988-11-01 | Lindstrom Richard L | Intraocular lens |
US5074876A (en) | 1987-12-04 | 1991-12-24 | Kelman Charles D | Two piece intraocular lens |
US5358520A (en) | 1989-04-28 | 1994-10-25 | Nestle S.A. | Supplementary intraocular lens system |
US4911715A (en) | 1989-06-05 | 1990-03-27 | Kelman Charles D | Overlapping two piece intraocular lens |
US5222981A (en) * | 1991-08-15 | 1993-06-29 | Werblin Research & Development Corp. | Multi-component intraocular lens |
US5141507A (en) * | 1991-12-06 | 1992-08-25 | Iolab Corporation | Soft intraocular lens |
US6692525B2 (en) * | 1992-02-28 | 2004-02-17 | Advanced Medical Optics, Inc. | Intraocular lens |
US5201763A (en) * | 1992-02-28 | 1993-04-13 | Allergan, Inc. | Thin intraocular lens |
DE9208015U1 (en) | 1992-06-16 | 1992-09-17 | Awe, Burkhard, Dr.med., 4400 Münster | Intraocular lens capsule spreader |
US5306297A (en) * | 1992-07-06 | 1994-04-26 | Kabi Pharmacia Ophthalmics, Inc. | Intraocular lens haptic with enlarged anchoring head |
RU2033113C1 (en) * | 1992-09-10 | 1995-04-20 | Федоров Святослав Николаевич | Artificial crystalline lens |
US5589982A (en) | 1994-06-03 | 1996-12-31 | Rochester Photonics Corporation | Polychromatic diffractive lens |
FR2728459B1 (en) * | 1994-12-26 | 1997-07-25 | Guilbert Guillaume Benjamin Ge | INTRA-EYE LENS WITH CIRCULAR SUPPORT AND CELL ANTI-MIGRATION, FOR SMALL INCISION |
US5769889A (en) | 1996-09-05 | 1998-06-23 | Kelman; Charles D. | High myopia anterior chamber lens with anti-glare mask |
FR2770394B1 (en) * | 1997-10-31 | 1999-12-31 | Guilbert Pierre Joel Ben Lecoq | INTRAOCULAR DEVICE CARRYING A CLEANING PAD AND A CORRECTOR LENS |
FR2782912B1 (en) | 1998-09-07 | 2001-01-12 | Georges Baikoff | INTRAOCULAR IMPLANT OF PREVIOUS CHAMBER |
FR2784575B1 (en) | 1998-10-15 | 2000-12-22 | Megaoptic Gmbh | ACCOMMODATIVE INTRAOCULAR IMPLANT |
EP1138282A1 (en) * | 2000-03-30 | 2001-10-04 | Charles D. Kelman, M.D. | Intraocular lens assembly |
US6425917B1 (en) * | 2000-05-12 | 2002-07-30 | Tekia | Phakic iol film frame |
US6413277B1 (en) * | 2000-05-18 | 2002-07-02 | Tobias H. Neuhann | Method for intraocular lens insertion and apparatus |
US20020022882A1 (en) * | 2000-08-17 | 2002-02-21 | Morgan Courtney Flem | Rollable intraocular lens having reduced thickness |
US20020173846A1 (en) * | 2001-02-01 | 2002-11-21 | Larry Blake | Two part "L"- or "S"-shaped phakic IOL |
US6656223B2 (en) * | 2001-08-30 | 2003-12-02 | Advanced Medical Optics, Inc. | Foldable intraocular lenses with highly flexible optics and rigid fixation members |
-
2000
- 2000-08-04 US US09/631,576 patent/US7462194B1/en not_active Expired - Fee Related
-
2001
- 2001-07-19 EP EP01954823A patent/EP1307164B1/en not_active Expired - Lifetime
- 2001-07-19 WO PCT/US2001/022947 patent/WO2002011649A2/en active IP Right Grant
- 2001-07-19 AT AT01954823T patent/ATE342700T1/en not_active IP Right Cessation
- 2001-07-19 AU AU2001277043A patent/AU2001277043A1/en not_active Abandoned
- 2001-07-19 CA CA002417966A patent/CA2417966A1/en not_active Abandoned
- 2001-07-19 JP JP2002516988A patent/JP2004505667A/en active Pending
- 2001-07-19 DE DE60123964T patent/DE60123964D1/en not_active Expired - Lifetime
-
2007
- 2007-10-31 US US11/980,387 patent/US20080125862A1/en not_active Abandoned
Cited By (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8752958B2 (en) | 1999-03-01 | 2014-06-17 | Boston Innovative Optics, Inc. | System and method for increasing the depth of focus of the human eye |
US9138142B2 (en) | 2003-05-28 | 2015-09-22 | Acufocus, Inc. | Masked intraocular devices |
US12076229B2 (en) | 2004-04-29 | 2024-09-03 | Forsight Vision6, Inc. | Accommodating intraocular lens assemblies and accommodation measurement implant |
US10912643B2 (en) | 2004-04-29 | 2021-02-09 | Forsight Vision6, Inc. | Accommodating intraocular lens assemblies and accommodation measurement implant |
US9814568B2 (en) | 2005-03-30 | 2017-11-14 | Forsight Vision6, Inc. | Accommodating intraocular lens having dual shape memory optical elements |
US10166096B2 (en) | 2005-03-30 | 2019-01-01 | Forsight Vision6, Inc. | Foldable accommodating intraocular lens |
US10966818B2 (en) | 2005-03-30 | 2021-04-06 | Forsight Vision6, Inc. | Accommodating intraocular lens (AIOL) assemblies, and discrete components therefor |
US12036110B2 (en) | 2005-03-30 | 2024-07-16 | Forsight Vision6, Inc. | Accommodating intraocular lens (AIOL) assemblies, and discrete components therefor |
US20110238173A1 (en) * | 2005-04-14 | 2011-09-29 | Acufocus, Inc. | Ophthalmic devices having a degradation resistant polymer |
US8287592B2 (en) | 2005-04-14 | 2012-10-16 | Acufocus, Inc. | Ophthalmic devices having a degradation resistant polymer |
US11786402B2 (en) | 2006-01-17 | 2023-10-17 | Alcon Inc. | Glaucoma treatment device |
US9398977B2 (en) | 2006-01-17 | 2016-07-26 | Transcend Medical, Inc. | Glaucoma treatment device |
US9668917B2 (en) | 2006-01-17 | 2017-06-06 | Novartis Ag | Drug delivery treatment device |
US10905590B2 (en) | 2006-01-17 | 2021-02-02 | Alcon Inc. | Glaucoma treatment device |
US9421130B2 (en) | 2006-01-17 | 2016-08-23 | Novartis Ag. | Glaucoma treatment device |
US9084662B2 (en) | 2006-01-17 | 2015-07-21 | Transcend Medical, Inc. | Drug delivery treatment device |
US9789000B2 (en) | 2006-01-17 | 2017-10-17 | Novartis Ag | Glaucoma treatment device |
US9107748B2 (en) | 2007-12-27 | 2015-08-18 | Forsight Labs, Llc | Intraocular, accommodating lens and methods of use |
US8414646B2 (en) | 2007-12-27 | 2013-04-09 | Forsight Labs, Llc | Intraocular, accommodating lens and methods of use |
US8715346B2 (en) | 2007-12-27 | 2014-05-06 | Forsight Labs, Llc | Intraocular, accommodating lens and methods of use |
US9050765B2 (en) | 2008-01-03 | 2015-06-09 | Forsight Labs, Llc | Intraocular, accommodating lens and methods of use |
US8167941B2 (en) | 2008-01-03 | 2012-05-01 | Forsight Labs, Llc | Intraocular, accommodating lens and methods of use |
US8573961B2 (en) | 2008-10-15 | 2013-11-05 | Guangzhou Vesber Biotechnology Co., Ltd | Mold for manufacturing a foldable artificial vitreous body |
US8419994B2 (en) * | 2008-10-15 | 2013-04-16 | Guangzhou Visbor Biotechnology Ltd. | Manufacturing method of foldable artificial vitreous body and mould thereof |
US20100286773A1 (en) * | 2008-10-15 | 2010-11-11 | Guangzhou Visbor Biotechnology Ltd. | Manufacturing method of foldable artificial vitreous body and mould thereof |
US8728158B2 (en) | 2009-02-09 | 2014-05-20 | Jeffrey C. Whitsett | Exchangeable intraocular lens device and method of use |
US20100204790A1 (en) * | 2009-02-09 | 2010-08-12 | Whitsett Jeffrey C | Exchangeable intraocular lens device and method of use |
US9005281B2 (en) | 2009-08-13 | 2015-04-14 | Acufocus, Inc. | Masked intraocular implants and lenses |
US9492272B2 (en) | 2009-08-13 | 2016-11-15 | Acufocus, Inc. | Masked intraocular implants and lenses |
WO2011163559A1 (en) * | 2010-06-25 | 2011-12-29 | Elenza, Inc. | Implantable ophthalmic devices with circularly asymmetric optic and methods |
US9913712B2 (en) | 2011-02-04 | 2018-03-13 | Forsight Labs, Llc | Intraocular accommodating lens and methods of use |
US11918458B2 (en) | 2011-02-04 | 2024-03-05 | Forsight Vision6, Inc. | Intraocular accommodating lens and methods of use |
US11076947B2 (en) | 2011-02-04 | 2021-08-03 | Forsight Vision6, Inc. | Intraocular accommodating lens and methods of use |
US10639141B2 (en) | 2011-02-04 | 2020-05-05 | Forsight Vision6, Inc. | Intraocular accommodating lens and methods of use |
US9545303B2 (en) | 2011-12-02 | 2017-01-17 | Acufocus, Inc. | Ocular mask having selective spectral transmission |
US9204962B2 (en) | 2013-03-13 | 2015-12-08 | Acufocus, Inc. | In situ adjustable optical mask |
US11771552B2 (en) | 2013-03-13 | 2023-10-03 | Acufocus, Inc. | In situ adjustable optical mask |
US10939995B2 (en) | 2013-03-13 | 2021-03-09 | Acufocus, Inc. | In situ adjustable optical mask |
US10350058B2 (en) | 2013-03-13 | 2019-07-16 | Acufocus, Inc. | In situ adjustable optical mask |
US9603704B2 (en) | 2013-03-13 | 2017-03-28 | Acufocus, Inc. | In situ adjustable optical mask |
US9427922B2 (en) | 2013-03-14 | 2016-08-30 | Acufocus, Inc. | Process for manufacturing an intraocular lens with an embedded mask |
US12226309B2 (en) | 2013-03-15 | 2025-02-18 | Alcon Inc. | Intraocular lens storage and loading devices and methods of use |
WO2014190029A1 (en) * | 2013-05-21 | 2014-11-27 | Transcend Medical, Inc. | Flow promoting ocular implant device and methods |
US9788999B2 (en) | 2013-05-21 | 2017-10-17 | Novartis Ag | Flow promoting ocular implant device and methods |
US11331182B2 (en) | 2014-03-28 | 2022-05-17 | Forsight Vision6, Inc. | Accommodating intraocular lens |
US12090044B2 (en) | 2014-03-28 | 2024-09-17 | Forsight Vision6, Inc. | Accommodating intraocular lens |
US10285805B2 (en) | 2014-03-28 | 2019-05-14 | Forsight Labs, Llc | Accommodating intraocular lens |
WO2017203517A1 (en) * | 2016-05-22 | 2017-11-30 | Joshua Ben Nun | Hybrid accommodating intraocular lens assemblages |
US11523898B2 (en) | 2016-10-28 | 2022-12-13 | Forsight Vision6, Inc. | Accommodating intraocular lens and methods of implantation |
US12303430B2 (en) | 2023-09-06 | 2025-05-20 | Alcon Inc. | Glaucoma treatment device |
Also Published As
Publication number | Publication date |
---|---|
CA2417966A1 (en) | 2002-02-14 |
JP2004505667A (en) | 2004-02-26 |
EP1307164A2 (en) | 2003-05-07 |
WO2002011649A3 (en) | 2002-06-06 |
ATE342700T1 (en) | 2006-11-15 |
EP1307164B1 (en) | 2006-10-18 |
AU2001277043A1 (en) | 2002-02-18 |
US7462194B1 (en) | 2008-12-09 |
DE60123964D1 (en) | 2006-11-30 |
WO2002011649A2 (en) | 2002-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7462194B1 (en) | Two part “L”-shaped phakic IOL | |
US6425917B1 (en) | Phakic iol film frame | |
US20020173846A1 (en) | Two part "L"- or "S"-shaped phakic IOL | |
US5776191A (en) | Fixation system for intraocular lens structures | |
US6755859B2 (en) | Iris fixated intraocular lenses | |
CA2361855C (en) | Iris fixated intraocular lens and instrument for attaching same to an iris | |
CA1237556A (en) | Fixation system for intraocularlens structures | |
EP1246587B1 (en) | Iris fixated intraocular lens | |
US6241777B1 (en) | Phakic intraocular lenses | |
US8197540B2 (en) | Ocular implant iris diaphragm | |
US20060116765A1 (en) | Refractive corrective lens (RCL) | |
US20020193877A1 (en) | Foldable iris fixated intraocular lenses | |
US20010044657A1 (en) | Phakic or aphakic intraocular lens assembly | |
KR20040105813A (en) | Accommodating intraocular lens with textured haptics | |
EP1138282A1 (en) | Intraocular lens assembly | |
WO2001087182A2 (en) | Injectable iris fixated intraocular lenses | |
US20040199248A1 (en) | Anterior chamber phakic lens and methods of implantation | |
JP2008544819A (en) | Foldable intraocular lens with adaptable support structure | |
EP1502560B1 (en) | Iris fixated intraocular lens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |